血液生物标志物的变化与心脏大小和功能的变化相关,在患有Fallot四重症的患者中
Wouter J van Genuchten1,2,3, Eva van den Bosch1,2,3, Saskia E Luijnenburg1,2
1Erasmus University Medical Center, Department of Pediatrics, Division of Pediatric Cardiology, Rotterdam, the Netherlands.
International journal of cardiology. Congenital heart disease
|December 23, 2024
概括
血液生物标志物的变化与手术后的Fallot四重症 (ToF) 患者的双心脏重塑相关. 这表明,在ToF修复后,炎症和免疫反应会影响心脏变化.
科学领域:
- 心脏病学 心脏病学
- 生物标志物 生物标志物
- 心脏成像 - - 心脏成像
背景情况:
- 费洛特四重法 (ToF) 手术修复可以导致不良的心脏重塑.
- 了解这种重塑背后的生物机制对于患者管理至关重要.
研究的目的:
- 为了研究血液生物标志物和双心膜大小/功能的变化之间的关系,在手术后的ToF患者.
- 为了确定与ToF修复后心脏重塑相关的特定生物标志物.
主要方法:
- 对50名ToF患者进行长度研究,重复进行血液生物标志物和心磁共振成像 (CMR) 分析.
- 评估的生物标志物包括NT-proBNP,ST2,GDF-15,DLK-1,IGFBP-1/7和FABP-4.这些生物标志物被认为是生物标志物.
- 用皮尔森相关系数来量化生物标志物和CMR变化之间的关系.
主要成果:
- 右心室 (RV) 尺寸的变化与NT-proBNP,ST2,GDF-15,IGFBP7和FABP-4有显著的相关性.
- 左心室 (LV) 尺寸变化与NT-pro-BNP,ST2,GDF-15和FABP-4有显著的相关性.
- 肺置换影响了NT-proBNP与RV大小的相关性.
结论:
- 在稳定的ToF患者中,血液生物标志物的变化反映了双心室大小和功能的变化.
- 这些发现凸显了炎症和免疫应对压力的作用在ToF修复后的心脏重塑中的作用.
更多相关视频
07:11Morphological and Functional Assessment of the Right Ventricle Using 3D Echocardiography
Published on: October 28, 2020
2.8K
09:05Assessment of Cardiac Morphological and Functional Changes in Mouse Model of Transverse Aortic Constriction by Echocardiographic Imaging
Published on: June 21, 2016
18.2K
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
100
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
100
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
57
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
57